MEXIDOL® in the Rehabilitation Treatment of Patients With Acute Cerebral Failure
Status:
COMPLETED
Trial end date:
2023-09-12
Target enrollment:
Participant gender:
Summary
The use of metabolic modulators creates prospects for increasing the efficiency of the rehabilitation treatment of patients with acute cerebral failure